medigraphic.com
SPANISH

Revista Mexicana de Anestesiología

ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number S1

<< Back Next >>

Rev Mex Anest 2016; 39 (S1)

Reasoning the therapeutic windows of intravenous agents in children

Rodríguez-Delgado NE, Muñoz-Cuevas JH
Full text How to cite this article

Language: Spanish
References: 13
Page: 70-72
PDF size: 178.5 Kb.


Key words:

No keywords

Text Extraction

No abstract.


REFERENCES

  1. Wilson G. Target controlled infusion anaesthesia in children. S Afr J Anaesthesiol Analg. 2010;16:124-126.

  2. Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci. 2013;102:2941-2952.

  3. Anderson B, Larsson P. A maturation model for midazolam clearance. Paediatr Anaesth. 2011;21:302-308.

  4. Anderson B, Hodkinson B. Are there still limitations for the use of target- control infusion in children? Curr Opin Anaesthesiol. 2010;23:356-362.

  5. Jeleazcov C, Ihmsen H, Schmidt J, et al. Pharmacodynamic modelling of the bispectral index response to propofol-based anaesthesia during general surgery in children. Br J Anaesth. 2008;100:509-516.

  6. Muñoz H, Cortinez L. Estimation of the plasma effect site equilibration rate constant (Ke0) of propofol in children using the time to peak effect. Anesthesiology. 2004;101:1269-1274.

  7. Fuentes R, Cortínez I, Ibacache M, et al. Propofol concentration to induce general anesthesia in children aged 3-11 years with the Kataria effect-site model. Paediatr Anaesth. 2015;25:554-559.

  8. West N, Dumont G, van Heusden K, et al. Robust closed-loop control of induction and maintenance of propofol anesthesia in children. Paediatr Anaesth. 2013;23:712-719.

  9. Muñoz H, León J, Fuentes R, et al. Prospective evaluation of the time to peak effect of propofol to target the effect site in children. Acta Anesthesiol Scand. 2009;53:883-890.

  10. Allegaert K, Peeters M, Verbesselt R. Inter-individual variability in propofol pharmacokinetics in preterm and term neonates. Br J Anaesth. 2007;99:864-870.

  11. Lundeberg S, Roelofse J. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Paediatr Anaesth. 2011;21:274-279.

  12. Pacifici GM. Clinical pharmacology of fentanyl in preterm infants. A review. Pediatr Neonatol. 2015;56:143-148.

  13. Sammartino M, Garra R, Sbaraglia F, et al. Remifentanil in children. Paediatr Anaesth. 2010;20:246-255.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Anest. 2016;39